What Olivia Munn's Diagnosis Can Help Us Understand About Breast Cancer Risk Assessment

A number, not a scan, started it

On March 13, 2024, Olivia Munn published a statement about her breast cancer diagnosis. Variety reported it in full. The part that stuck with people was not the diagnosis. It was the sequence.

"I wouldn't have found my cancer for another year — at my next scheduled mammogram — except that my OBGYN, Dr. Thaïs Aliabadi, decided to calculate my Breast Cancer Risk Assessment Score," she wrote. Her doctor weighed three things: her age, her family history of breast cancer, and having her first child after 30. The score put her lifetime risk at 37 percent.

That number sent her for an MRI, then an ultrasound, then a biopsy. The biopsy found cancer in both breasts, which she described as Luminal B. She had a double mastectomy 30 days later, after what she called a 10-hour operation.

Everything above is from her own statement. We add the medicine, and nothing about her care beyond what she published.

What a risk model is doing

A breast cancer risk model is arithmetic, not a test. It takes facts about a person and returns an estimated probability.

The inputs are things studies have tied to risk. Current age. Age at first period. Age at first birth. How many close relatives have had breast cancer. How many breast biopsies you have had, and what they showed.

NCI runs a free one, the Breast Cancer Risk Assessment Tool, also called the Gail Model. It estimates the chance of invasive breast cancer over the next five years, and up to age 90. It uses personal and reproductive history. It also uses breast cancer in first-degree relatives: mother, sisters, daughters.

Different models exist and they weight family history differently. Munn's statement did not name which one her doctor used, so we will not guess.

For scale: NCI reports that a woman born in the United States today has about a 1 in 8 lifetime chance of a breast cancer diagnosis, and about a 7 in 8 chance of never having one. A modeled figure well above that average is what moves a doctor to order imaging outside the routine schedule.

Why a normal mammogram is not the end of the story

Mammography is the screening test with randomized evidence behind it. It is also imperfect, and NCI's clinical review says so in numbers.

Invasive breast cancer is present but missed on mammography in 6 to 46 percent of exams, depending on the population studied. Misses are more likely with lobular and mucinous tumors. They are also more likely with fast-growing cancers that appear between scans, and in dense breast tissue, which is common in younger women.

That is the gap a risk score is meant to catch. NCI notes breast MRI has been promoted for women at high risk. That means carriers of BRCA1 or BRCA2 changes, a strong family history, or syndromes such as Li-Fraumeni or Cowden disease. MRI is more sensitive than mammography and less specific. It finds more cancers. It also raises more false alarms, and it costs far more.

None of that makes MRI a better test for everyone. It makes it a better test for a smaller group.

Where "Luminal B" comes from

The label is not from a pathology textbook. It came out of gene-expression research. In a 2001 study in the Proceedings of the National Academy of Sciences, Sørlie and colleagues sorted breast tumors by which genes they switched on. The estrogen-receptor-positive "luminal" group split into at least two subgroups. Each had its own profile and its own outcomes.

A treating team acts on more concrete labels. Estrogen and progesterone receptor status. HER2 status. Grade and stage. Sometimes a multi-gene test such as Oncotype DX, which returns a recurrence score. Our page on breast cancer explains how those pieces fit together.

When to raise this at an appointment

A risk score is a conversation, and it is free to ask for. Reasons to start it:

• Breast or ovarian cancer in a parent, sibling, or child. This matters most before age 50, or in more than one relative.
• A previous breast biopsy, particularly one reported as atypical hyperplasia or lobular carcinoma in situ.
• A mammogram report saying your breasts are heterogeneously or extremely dense.
• Ashkenazi Jewish ancestry, or a known BRCA1, BRCA2, or other cancer-gene change in the family.
• Chest radiation before age 30, for example for Hodgkin lymphoma.

Separately, and regardless of any score: a new lump, a change in breast shape, skin dimpling, nipple inversion, or bloody nipple discharge is a reason for an appointment now, not at the next scheduled scan. Our guide to cancer screening sets out what routine testing does and does not cover.

What this does not mean

• A risk score is not a diagnosis. A high number does not mean cancer is present. A low one does not rule it out.
• The threshold Munn quoted came from her physician's practice. Thresholds for adding MRI vary between guidelines, and the decision is individual.
• Genetic testing and risk modeling are different things. Genetic testing looks for an inherited change in a specific gene. A risk model estimates probability from history, whether or not any gene change is found.
• More imaging is not automatically better. NCI's review estimates that 20 to 50 percent of screen-detected cancers represent overdiagnosis — cancers that would never have caused harm — and there is no reliable way to tell which.
• One person's route to a diagnosis is not a protocol. It is a reason to have the conversation, not a template for it.

Sources

• Variety: Olivia Munn reveals breast cancer diagnosis and double mastectomy procedure
• National Cancer Institute — About the Breast Cancer Risk Assessment Calculator (the Gail Model)
• National Cancer Institute — Breast Cancer Risk Assessment Calculator
• NCI PDQ: Breast Cancer Screening (Health Professional Version)
• NCI: Breast Cancer Risk in American Women
• Sørlie T, Perou CM, Tibshirani R, et al., PNAS 2001, PMID 11553815 — record retrieved via NCBI eutils

How this article was prepared

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

Cancer Explained is published by the National Cancer Information Foundation. It is not medical advice and does not suggest a test or treatment.

See an error, old source, or unclear wording? Tell us.